Buprenex Related Published Studies
Well-designed clinical trials related to Buprenex (Buprenorphine)
Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. [2008.09]
Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. [2008.08]
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study. [2008.08]
Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. [2008.07]
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. [2008.07]
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. [2008.06.28]
Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs. [2008.06]
Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. [2008.05]
Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain. [2008.04.12]
Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial. [2008.04.01]
Buprenorphine injection to the stellate ganglion in the treatment of upper body chronic pain syndromes. [2008.04]
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. [2008.03]
Comparison between analgesic effects of buprenorphine, carprofen, and buprenorphine with carprofen for canine ovariohysterectomy. [2008.01]
Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects. [2008.01]
Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects. [2008.01]
QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial. [2007.12.10]
Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. [2007.12.01]
A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. [2007.12]
Carprofen and buprenorphine prevent hyperalgesia in a model of inflammatory pain in cats. [2007.12]
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. [2007.10.08]
A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. [2007.09.03]
Effect of intra-articular administration of buprenorphine after arthrocentesis of the temporomandibular joint: a pilot study. [2007.09]
A comparison of tepoxalin-buprenorphine combination and buprenorphine for postoperative analgesia in dogs: a clinical study. [2007.09]
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. [2007.08]
Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. [2007.08]
Buprenorphine injection to the stellate ganglion in the treatment of upper body chronic pain syndromes. [2007.07.14]
Clinical pharmacology of buprenorphine in healthy, lactating goats. [2007.06]
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry. [2007.05.01]
A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. [2007.05]
Assessment of buprenorphine, carprofen, and their combination for postoperative analgesia in olive baboons (Papio anubis). [2007.05]
Effects of buprenorphine on nociception and spontaneous locomotor activity in horses. [2007.03]
Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. [2007.02]
Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial. [2007.01.08]
Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. [2007.01.01]
Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. [2007.01]
Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine. [2006.12.15]
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. [2006.12]
Effects of two doses of buprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dogs after castration. [2006.11.18]
Investigation of the interaction between buprenorphine and sufentanil during anaesthesia for ovariectomy in dogs. [2006.11]
Clinical efficacy and safety of dexmedetomidine and buprenorphine, butorphanol or diazepam for canine hip radiography. [2006.11]
Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine. [2006.11]
Comparison of intravenous patient-controlled analgesia with buprenorphine versus morphine after lumbar spinal fusion--a prospective randomized clinical trial. [2006.09]
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. [2006.09]
Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine. [2006.08.08]
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. [2006.07.27]
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. [2006.06]
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. [2006.06]
Comparison of intrathecal fentanyl and buprenorphine in urological surgery. [2006.06]
A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine. [2006.05]
Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine. [2006.03.15]
A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers. [2006.03]
[No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery] [2006.02]
Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. [2006.02]
Evaluation of signs of postoperative pain and complications after forelimb onychectomy in cats receiving buprenorphine alone or with bupivacaine administered as a four-point regional nerve block. [2006.01.01]
Opioid-induced respiratory effects: new data on buprenorphine. [2006]
Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants. [2006]
A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial. [2005.12]
Opioid plasma concentrations in methadone-and buprenorphine-maintained patients. [2005.12]
Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms. [2005.12]
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. [2005.11]
Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. [2005.11]
PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. [2005.10]
Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial. [2005.10]
Effects of pre- versus post-anaesthetic buprenorphine on propofol-anaesthetized rats. [2005.09]
Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. [2005.08.24]
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. [2005.08]
Use of sublingual buprenorphine for pain relief in office hysteroscopy. [2005.07]
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? [2005.07]
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. [2005.07]
Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone. [2005.06]
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. [2005.06]
Addition of 0.1% bupivacaine to buprenorphine and droperidol in patient-controlled epidural analgesia improved postoperative pain scores on coughing after gynecological surgery. [2005.05]
Anti-nociceptive efficacy of carprofen, levomethadone and buprenorphine for pain relief in cats following major orthopaedic surgery. [2005.05]
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. [2005.05]
Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. [2005.04.04]
Influence of psychotherapy attendance on buprenorphine treatment outcome. [2005.04]
A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence. [2005.03]
Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing. [2005.02.14]
Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. [2005.02]
[Buprenorphine and methadone to opiate addicts--a randomized trial] [2005.01.20]
A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin. [2005.01.07]
Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. [2005.01]
Pain management after lumbar spinal fusion surgery using continuous subcutaneous infusion of buprenorphine. [2005]
A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. [2005]
Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence. [2004.12]
Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. [2004.11]
Evaluation of an injection depot formulation of buprenorphine: placebo comparison. [2004.11]
Opioid detoxification using high doses of buprenorphine in 24 hours: a randomized, double blind, controlled clinical trial. [2004.07]
A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal. [2004.06]
Network therapy: decreased secondary opioid use during buprenorphine maintenance. [2004.06]
A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. [2004.05.10]
Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. [2004.03]
Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification. [2004.01.07]
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. [2004.01]
Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial. [2004]
Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. [2004]
The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving. [2003.12.11]
Improvement in postoperative pain relief by the addition of midazolam to an intrathecal injection of buprenorphine and bupivacaine. [2003.11]
Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine. [2003.10.11]
Controlled trial of maintenance treatment of intravenous buprenorphine dependence. [2003.10]
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. [2003.09.04]
|
